National vaccination programs are being rolled out based on the readiness assessments prepared by the W BG and the W HO, which also provide indications on where to channel resources to address weaknesses in national health systems. Such efforts may be impeded by the uncertainty surrounding vaccine availability.
We encourage IFC and MIGA to play a galvanizing, entrepreneurial role in improving vaccine manufacturing capacity at the national or regional level, in coordination with other DFIs and partners in the private sector. International coordination, sharing of pandemic plans, and collaborative disease monitoring and diagnosis are necessary steps toward long-term health preparedness and resilience.